Evidence map›Paper›PMID 39495223›Full record

ArticleeLife2024

Cell-autonomous targeting of arabinogalactan by host immune factors inhibits mycobacterial growth.

Lianhua Qin, Junfang Xu, Jianxia Chen, Sen Wang, Ruijuan Zheng, Zhenling Cui, Zhonghua Liu, Xiangyang Wu, Jie Wang, Xiaochen Huang and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in eLife, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Protein Architecture and Composition in Mycobacterium tuberculosis.Advances in experimental medicine and biology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Lianhua Qin *Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Junfang Xu *Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0002-4150-7305
Jianxia Chen *Shanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Sen Wang *Department of Infectious Diseases, National Medical Centre for Infectious Diseases, National Clinical Research Centre for Aging and Medicine, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Huashan Hospital, Fudan University, Shanghai, China.
Ruijuan ZhengShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Zhenling CuiShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Zhonghua LiuShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Xiangyang WuShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Jie WangShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Xiaochen HuangShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Zhaohui WangAbmart Inc, Shanghai, China.
Mingqiao WangAbmart Inc, Shanghai, China.
Rong PanAbmart Inc, Shanghai, China.
Stefan H E KaufmannMax Planck Institute for Infection Biology, Berlin, Germany.ORCID https://orcid.org/0000-0001-9866-8268
Xun MengAbmart Inc, Shanghai, China.
Lu ZhangSchool of Life Science, Fudan University, Shanghai, China.
Wei ShaShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Haipeng LiuShanghai Key Laboratory of Tuberculosis, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.ORCID https://orcid.org/0000-0002-3338-6291

Funding

Excellent Young Scientists Fund 81922030National Key Research and Development Program of China 2021YFA1300902National Key Research and Development Program of China 2023YFC2307002National Natural Science Foundation of China 81470090National Natural Science Foundation of China 82000009National Natural Science Foundation of China 82201931National Natural Science Foundation of China 82271882Science and Technology Commission of Shanghai Municipality 21DZ229800Science and Technology Commission of Shanghai Municipality 22S11900700Science and Technology Commission of Shanghai Municipality 22ZR1452500Shanghai Shuguang Program 20SG19Tongji University 22120220655
6 · The paper itself

Abstract

Deeper understanding of the crosstalk between host cells and

Indexed as

GalactansGalectinsMycobacterium tuberculosisAnimalsAntibodies, MonoclonalCell WallFemaleHost-Pathogen InteractionsHumansImmunologic FactorsMiceTuberculosisAntibodies, MonoclonalarabinogalactanGalactansGalectinsImmunologic FactorsLGALS9 protein, humanantibodyarabinogalactanbacteriagalectin-9infectious diseasemicrobiologyMycobacterium tuberculosistuberculosis

Identifiers

PMID39495223
PMCPMC11534329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.